Vertex Receives Two EU Approvals for KALYDECO for Cystic Fibrosis
November 18, 2015 at 04:19 AM EST
Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced that the European Commission has approved ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.